Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $95,437 - $105,968
-1,498 Reduced 2.32%
62,949 $4.03 Million
Q1 2023

Apr 10, 2023

SELL
$65.71 - $74.53 $89,759 - $101,807
-1,366 Reduced 2.08%
64,447 $4.47 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $226,463 - $268,164
-3,307 Reduced 4.78%
65,813 $4.73 Million
Q2 2022

Sep 06, 2022

SELL
$72.62 - $79.98 $3.24 Million - $3.56 Million
-44,555 Reduced 39.2%
69,120 $5.32 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $140,297 - $168,229
-2,282 Reduced 1.97%
113,675 $8.3 Million
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $173,224 - $201,939
-3,230 Reduced 2.71%
115,957 $7.23 Million
Q3 2021

Dec 07, 2021

BUY
$59.17 - $69.31 $601,581 - $704,674
10,167 Added 9.33%
119,187 $7.05 Million
Q1 2021

Apr 21, 2021

BUY
$59.34 - $66.74 $806,430 - $906,996
13,590 Added 14.24%
109,020 $6.88 Million
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $721,750 - $817,875
12,500 Added 15.07%
95,430 $5.92 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $546,128 - $793,651
-11,770 Reduced 12.43%
82,930 $4.62 Million
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $4.66 Million - $6.08 Million
94,700 New
94,700 $6.08 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Guinness Atkinson Asset Management Inc Portfolio

Follow Guinness Atkinson Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guinness Atkinson Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guinness Atkinson Asset Management Inc with notifications on news.